ACR Attends 2025 RUC Meetings
ACR participated in the American Medical Association/Specialty Society RVS Update Committee meeting where they heard updates on the AMA Physician Practice Information Survey.
Read moreMain Content
Feds Issue Information Notice Regarding Radiopharmaceutical Therapies
Sept. 4, 2024
The U.S. Nuclear Regulatory Commission (NRC) issued Information Notice 2024-04 Aug. 9, to inform licensees of recent reported medical events that involved the administration of therapeutic radiopharmaceuticals.
The notice is intended to notify licensed facilities and personnel of 29 medical events from federal fiscal year 2021 through 2023, caused primarily by lack of confirmation, validation or implementation of written directives. It does not provide information regarding the specialties/professions or institutions involved; however, it does mention that several of these medical events occurred due to coordination or communication issues with departments other than the department that administered the radiopharmaceutical.
Moving forward, medical licensees and authorized personnel that offer radiopharmaceutical therapies should review the notice and apply lessons learned to inter- and intra-departmental training and protocols to avoid similar medical events in the future.
If you have questions or would like more information, contact Michael Peters, American College of Radiology® Senior Director of Government Affairs.
The notice is intended to notify licensed facilities and personnel of 29 medical events from federal fiscal year 2021 through 2023, caused primarily by lack of confirmation, validation or implementation of written directives. It does not provide information regarding the specialties/professions or institutions involved; however, it does mention that several of these medical events occurred due to coordination or communication issues with departments other than the department that administered the radiopharmaceutical.
Moving forward, medical licensees and authorized personnel that offer radiopharmaceutical therapies should review the notice and apply lessons learned to inter- and intra-departmental training and protocols to avoid similar medical events in the future.
If you have questions or would like more information, contact Michael Peters, American College of Radiology® Senior Director of Government Affairs.
Related ACR News
NCI Releases FY 2027 Budget Proposal
Anthony Letai, MD, PhD, became NCI Director Sept. 29, leading with a $7.2B budget and proposing $11.5B for FY 2027 to boost cancer research.
Read moreLead the Future of Alzheimer's Imaging
Join ALZ-NET Imaging Network to access AI tools, boost Alzheimer’s imaging, and contribute data to shape FDA safety and clinical guidelines.
Read more